Human prostatic carcinoma cell lines display altered regulation of polyamine transport in response to polyamine analogs and inhibitors

Prostate

Volumn 34, Issue 1, 1998, Pages 51-60

  Mi, Z ^a   Kramer, D L ^a   Miller, J T ^a   Bergeron, R J ^b   Bernacki, R ^a   Porter, C W ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

CGP 48664; DENSPM; Inhibitors; N1,N11 diethylnorspermine; Ornithine decarboxylase; Polyamine analogs; Polyamines; Prostate; Regulation; S adenosylmethionine decarboxylase; Spermidine; Spermidine spermin e N1 acetyltransferase; Spermine; Transport

Indexed keywords

4 AMIDINO 1 INDANONE 2' AMIDINOHYDRAZONE; ADENOSYLMETHIONINE DECARBOXYLASE; DECARBOXYLASE INHIBITOR; N1,N11 DIETHYLNORSPERMINE; POLYAMINE DERIVATIVE;

ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; POLYAMINE METABOLISM; PRIORITY JOURNAL; PROSTATE CARCINOMA; TRANSPORT KINETICS;

ADENOSYLMETHIONINE DECARBOXYLASE; AMIDINES; BIOLOGICAL TRANSPORT; GROWTH INHIBITORS; HUMANS; INDANS; MALE; MOLECULAR STRUCTURE; POLYAMINES; PROSTATIC NEOPLASMS; SPERMIDINE; SPERMINE; TUMOR CELLS, CULTURED;

EID: 0031983566     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19980101)34:1<51::AID-PROS7>3.0.CO;2-N     Document Type: Article

References (46)

1. Raghavan D, Rogers J: Update in the management of prostate cancer. Med J Aust 1990;152:419-426.
2. Raghavan D: Non-hormone chemotherapy for prostate cancer: Principles of treatment and application to the testing of new drugs. Semin Oncol 1988;15:371-389.
3. Pegg AE: Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res 1988; 48:759-774.
4. Marton LJ, Pegg AE: Polyamines as targets for therapeutic intervention. Annu Rev Pharmacol Toxicol 1995;35:55-91.
5. Porter CW, Regenass U, Bergeron RJ: Polyamine inhibitors and analogs as potential anticancer agents. In Dowling RH, Folsch UR, Loser C (eds): "Falk Symposium on Polyamines In the Gastrointestinal Tract." Dordrecht: Kluwer Academic Publishers, 1992:301-322.
6. Stanek J, Cravatti G, Frei J, Furet P, Mett H, Schneider P, Regenass U: 4-amidinoindan-1-one 2′-amidonhydrazone: A new potent selective inhibitor of S-adenosylmethionine decarboxylase. J Med Chem 1993;36:2168-2171.
7. Regenass U, Mett H, Stanek J, Muller M, Kramer D, Porter CW: CGP-48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity. Cancer Res 1994;54:3210-3217.
8. Kramer DL, Mett H, Regenass U, Diegelman P, Porter CW: Stable amplification of the S-adenosylmethionine decarboxylase gene in Chinese hamster ovary cells. J Biol Chem 1995;270:2124-2132.
9. Bergeron RJ, Hawthorne TR, Vinson JRT, Beck DE, Ingeno MJ: Role of the methylene backbone in the antiproliferative activity of polyamine analogues on L1210 cells. Cancer Res 1989;49: 2959-2964.
10. 1-acetyltransferase activity and growth inhibition in human melanoma cell lines. Cancer Res 1991;51:3715-3720.
11. 12-bis(ethyl)spermine and related compounds on growth and polyamine acetylation, content, and excretion in human colon tumor cells. J Biol Chem 1989;264:11744-11749.
12. Delworth MG, Nishioka K, Pettaway C, Gutman M, Killion JJ, von Eschenbach AC, Fidler IJ: Systemic administration of 4-amidinoindanon-1-(2′-amidino)-hydrazone, a new inhibitor of S-adenosylmethionine decarboxylase, produces cytostasis of human prostate cancer in athymic nude mice. Int J Oncol 1995; 6:293-299.
13. 12-bis(ethyl)spermine homologs against human MALME-3 melanoma xenografts. Cancer Res 1992;52:2424-2430.
14. 11-diethylnorspermine. Clin Cancer Res 1995;1:847-857.
15. 11-bis(ethyl)-norspermine against human melanoma xenografts and possible biochemical correlates of drug action. Cancer Res 1993;53:581-586.
16. Williams-Ashman HG, Canellakis ZN: Polyamines in mammalian biology and medicine. Perspect Biol Med 1979;22:421-453.
17. Heston WDW, Watanabe KA, Pankiewicz KW, Covey DF: Cytotoxic and noncytotoxic N-alkyl derivatives of putrescine effect on polyamine uptake and growth of prostatic cancer cells in vitro. Biochem Pharmacol 1987;36:1849-1852.
18. Heston WDW: Prostatic polyamines and polyamine targeting as a new approach to therapy of prostatic cancer. Cancer Surv 1991;11:217-238.
19. Harrison GA: Spermine in human testis. Biochem J 1931;25: 1885-1892.
20. Smith RC, Litwin MS, Lu Y, Zetter BR: Identification of an endogenous inhibitor of prostatic carcinoma cell growth. Nat Med 1995;1:10140-10145.
21. McKloskey DE, Prestigiacomo LJ, Woster PM, Casero RA, Davidson NE: Growth and biochemical effects of symmetrically and unsymmetrically substituted polyamine analogues on human prostate cancer cell lines. Proc Am Assoc Cancer Res 1996;37: 400.
22. Bergeron RJ, Neims AH, McManis JS, Hawthorne TR, Vinson JRT, Bortell R, Ingeno MJ: Synthetic polyamine analogues as antineoplastics. J Med Chem 1988;31:1183-1190.
23. Bergeron RJ, McManis JS, Liu CZ, Feng Y, Weimar WR, Luchetta GR, Wu Q, Ortiz-Ocasio J, Vinson JRT, Kramer D, Porter CW: Antiproliferative properties of polyamine analogs: A structure activity study. J Med Chem 1994;37:3464-3476.
24. Hickok NJ, Seppanen PJ, Gunsahis GL, Janne OA: Complete amino acid sequence of human ornithine decarboxylase deduced by complementary DNA. DNA 1987;6:179-187.
25. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA, Murphy GP: LNCaP model of human prostatic cancer. Cancer Res 1983;43:1809-1818.
26. Mickey DD, Stone KR, Wunderli U, Mickey GH, Vollmer RT, Paulson DF: Heterotransplantation of a human prostatic adenocarcinoma cell line in nude mice. Cancer Res 1978;37:4049-4058.
27. Kaighn ME, Shankar-Narayan K, Ohnuki Y, Lechner JF, Jones LW: Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 1979;17:16-23.
28. Shore PA, Cohn VH: Comparative effects of monoamine oxidase inhibition on monoamine oxidase and diamine oxidase. Biochem Pharmacol 1960;5:91-95.
29. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR: New colorimetric cytotoxicity assay for anticancer-drug screening. JNCI 1990; 82:1107-1112.
30. Kramer DL, Miller JM, Khomutov R, Khomutov A, Bergeron RJ, Porter CW: Regulation of polyamine transport by polyamines and polyamine analogs. J Cell Physiol 1193;115:399-407.
31. Yarlett N, Bacchi CJ: Effect of DL-α-difluoromethylornithine on methionine cycle intermediates in Trypanosoma brucei brucei. Mol Biochem Parasitol 1988;27:1-10.
32. 1-acetyltransferase mRNA accumulation in MALME-3M human melanoma cells. J Biol Chem 1993;268: 19118-19125.
33. Mamont PS, Duchesne M-C, Grove J, Tardif, C: Initial characterization of a HTC cell variant partially resistant to the antiproliferative effects of ornithine decarboxylase inhibitors. Exp Cell Res 1978;115:387-393.
34. McKloskey DE, Yang J, Woster PM, Davidson NE, Casero RA: Polyamine analogue induction of programmed cell death in human lung tumor cells. Clin Cancer Res 1996;2:441-446.
35. Kakinuma Y, Hoshino K, Igarashi K: Characterization of the inducible polyamine transporter in bovine lymphocytes. Eur J Biochem 1988;176:409-414.
36. Byers TL, Pegg AE: Regulation of polyamine transport in Chinese hamster ovary cells. J Cell Physiol 1990;143:460-467.
37. Kramer DL: Polyamine inhibitor and analogs. In Nishioka K (ed): "Critical Roles of Polyamines in Cancer: Basic Mechanisms and Clinical Approaches." New York: R.G. Landes Co., 1996: 151-189.
38. Seiler N, Sarhan S, Mamont P, Casara P, Danzin C: Some biological consequences of S-adenosylmethionine decarboxylase inhibition by MDL 73811. Life Chem Rep 1991;9:151-162.
39. Dorhout B, te Velde RJ, Ferwada H, Kingma AW, Muskiet FA: In vivo effects of 4-amidinoindane-1-one 2′ amidinohydrazone (CGP-48664) and alpha-difluoromethylornithine (DFMO) on L1210 cell growth, cell cycle phase distribution and polyamine contents. Int J Cancer 1995;62:738-742.
40. 1-acetyltransferase in human lung cancer cells by the bis(ethyl)polyamine analogues. Cancer Res 1989;49:3829-3833.
41. 12-bis(ethyl)spermine, and its relationship to polyamine structure and function. Mol Pharmacol 1991;39:487-494.
42. He Y, Suzuki T, Kashiwagi K, Kusama-Eguchi K, Shirahata A, Igarashi K: Correlations between inhibition of cell growth by bis(ethyl)polyamine analogues and the decrease in function of mitochondria. Eur J Biochem 1994;221:391-398.
43. Snyder RD, Beach DC, Loudy DE: Antimitochondrial effects of bisethyl polyamines in mammalian cells. Anticancer Res 1994; 14:347-356.
44. Mitchell JLA, Judd GG, Bareyal-Leyser A, Ling SY: Feedback repression of polyamine transport is mediated by antizyme in mammalian tissue culture cells. Biochem J 1994;299:19-22.
45. Suzuki T, He Y, Kashiwagi K, Murakami Y, Hayashi S, Igarashi K: Antizyme protects against abnormal accumulation and toxicity of polyamines in ornithine decarboxylase-overproducing cells. Proc Natl Acad Sci USA 1994;91:8930-8934.
46. Hayashi S, Murakami Y: Rapid and regulated degradation of ornithine decarboxylase. Biochem J 1995;306:1-10.